American Journal of Kidney Diseases
Volume 46, Issue 2 , Pages 278-282 , August 2005

Focal and Segmental Glomerulosclerosis and Plasma Cell Proliferative Disorders

Received 21 March 2005 ,Accepted 2 May 2005.

References 

  1. Kitiyakara C , Kopp JB , Eggers P . Trends in the epidemiology of focal segmental glomerulosclerosis . Semin Nephrol . 2003;23:172–182
  2. Schnaper HW . Idiopathic focal segmental glomerulosclerosis . Semin Nephrol . 2003;23:183–193
  3. Cameron JS . Focal segmental glomerulosclerosis in adults . Nephrol Dial Transplant . 2003;18(suppl 6):Svi45–Svi51
  4. Chen R , Matthews JH , Jackson AC . Large granular lymphoproliferative disease associated with nephrotic syndrome, renal failure and leukoencephalopathy . Leuk Lymphoma . 1993;11:129–133
  5. Calvo Villas JM , Morales Umpierrez A , Ramirez Sanchez MJ , et al.   Focal and segmental glomerulosclerosis and non-Hodgkin’s lymphoma . Clin Nephrol . 2002;57:173–174
  6. Lin FC , Chen JY , Yang AH , et al.   The association of non-small-cell lung cancer, focal segmental glomerulosclerosis, and platelet dysfunction . Am J Med Sci . 2002;324:161–165
  7. Markowitz GS , Appel GB , Fine PL , et al.   Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate . J Am Soc Nephrol . 2001;12:1164–1172
  8. Shah S , Cavenagh J , Sheaf M , et al.   Remission of collapsing focal segmental glomerulosclerosis following chemotherapy for myeloma . Am J Kidney Dis . 2004;43:e10–e12
  9. Kyle RA , Therneau TM , Rajkumar SV , et al.   Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance (The original Mayo Clinic series 25 years later) . Mayo Clinic Proc . 2004;79:859–866
  10. Kyle RA . Monoclonal gammopathy of undetermined significance. Natural history in 241 cases . Am J Med . 1978;64:814–826
  11. Kyle RA . “Benign” monoclonal gammopathy—After 20 to 35 years of follow-up . Mayo Clinic Proc . 1993;68:26–36
  12. Bataille R , Harousseau JL . Multiple myeloma . N Engl J Med . 1997;336:1657–1664
  13. Kyle RA . Diagnosis of multiple myeloma . Semin Oncol . 2002;29:2–4
  14. Markowitz GS . Dysproteinemia and the kidney . Adv Anat Pathol . 2004;11:49–63
  15. Desikan R , Veksler Y , Raza S , et al.   Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma . Br J Haematol . 2002;119:496–499
  16. Kyle RA . Monoclonal gammopathy of undetermined significance . Blood Rev . 1994;8:135–141
  17. Cameron JS . The enigma of focal segmental glomerulosclerosis . Kidney Int Suppl . 1996;57:S119–S131
  18. Kyle RA , Therneau TM , Rajkumar SV , et al.   Prevalence of monoclonal gammopathy of undetermined significance (MGUS) among Olmsted County, Minnesota residents > 50 years of age . Blood . 2003;102:934A; (abstr 3476)
  19. D’Agati V . The many masks of focal segmental glomerulosclerosis . Kidney Int . 1994;46:1223–1241
  20. Korbet SM . Primary focal segmental glomerulosclerosis . J Am Soc Nephrol . 1998;9:1333–1340
  21. Matsuyama N , Joh K , Yamaguchi Y , et al.   Crystalline inclusions in the glomerular podocytes in a patient with benign monoclonal gammopathy and focal segmental glomerulosclerosis . Am J Kidney Dis . 1994;23:859–865
  22. Paueksakon P , Revelo MP , Horn RG , et al.   Monoclonal gammopathy (Significance and possible causality in renal disease) . Am J Kidney Dis . 2003;42:87–95
  23. Lewis DR , Pottern LM , Brown LM , et al.   Multiple myeloma among blacks and whites in the United States (The role of chronic antigenic stimulation) . Cancer Causes Control . 1994;5:529–539
  24. Franceschini N , Hogan SL , Falk RJ . Primum non nocere (Should adults with idiopathic FSGS receive steroids?) . Semin Nephrol . 2003;23:229–233
  25. Brenchley PE . Vascular permeability factors in steroid-sensitive nephrotic syndrome and focal segmental glomerulosclerosis . Nephrol Dial Transplant . 2003;18(suppl 6):Svi21–Svi25
  26. Rajkumar SV , Kyle RA . Angiogenesis in multiple myeloma . Semin Oncol . 2001;28:560–564
  27. Rajkumar SV , Mesa RA , Fonseca R , et al.   Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis . Clin Cancer Res . 2002;8:2210–2216
  28. Kelly T , Miao HQ , Yang Y , et al.   High heparanase activity in multiple myeloma is associated with elevated microvessel density . Cancer Res . 2003;63:8749–8756

 Originally published online as doi:10.1053/j.ajkd.2005.05.004 on June 24, 2005.Supported by grant CA62242 from the National Cancer Institute.

PII: S0272-6386(05)00617-7

doi: 10.1053/j.ajkd.2005.05.004

American Journal of Kidney Diseases
Volume 46, Issue 2 , Pages 278-282 , August 2005

Article Tools

* Image Usage & Resolution